¼¼°èÀÇ À§ ¿°Àü Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Gastric Volvulus Treatment Global Market Report 2025
»óǰÄÚµå : 1821678
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,457,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,334,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,211,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À§ ¿°Àü Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â¿¡ CAGRÀº 6.5%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµÇ°í 371¾ï 8,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ±ÔÁ¦ º¯È­ ¹× ½ÂÀÎ, ¼ö¼ú ÀýÂ÷ÀÇ Çõ½Å, °í·É Àα¸ Áõ°¡, ¸ÂÃãÇü Ä¡·á °èȹ, ÷´Ü ¿µ»ó ±â¼ú µµÀÔ µî¿¡ ±âÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿Çâ¿¡´Â ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¼ú, ÀÎ½Ä Á¦°í ¹× Á¶±â °³ÀÔ, Ä¡·á ¹æ½Ä ¿¬±¸, Çù·ÂÀû ÀÇ·á °üÇà, ¸ÂÃãÇü Ä¡·á Á¢±Ù¹ýÀÌ Æ÷ÇԵ˴ϴÙ.

ÇâÈÄ 5³â°£ 6.5% ¼ºÀå Àü¸ÁÀº ÀÌÀü ¿¹Ãø ´ëºñ 0.2% ¼ÒÆø Ç϶ôÇÑ ¼öÄ¡´Ù. ÀÌ Ç϶ôÀº ÁÖ·Î ¹Ì±¹°ú Ÿ±¹ °£ °ü¼¼ ¿µÇâ ¶§¹®ÀÔ´Ï´Ù. °ü¼¼ À庮Àº ºê¶óÁú°ú Áß±¹¿¡¼­ ¿øÇÏ´Â º¹°­°æ °¨¾Ð Àåºñ ¹× ºñÀ§Æ©ºê ºñ¿ëÀ» Áõ°¡½ÃÄÑ ÀÀ±Þ ¼ö¼ú Ä¡·á¸¦ ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â »ý¸íÀ» ±¸ÇÏ´Â ½Ã¼úÀ» Áö¿¬½Ã۰í ÀÏ¹Ý ¿Ü°ú ºñ¿ëÀ» »ó½Â½Ãų °ÍÀÔ´Ï´Ù. ¶ÇÇÑ »óÈ£ °ü¼¼ ºÎ°ú¿Í ¹«¿ª ±äÀå ¹× Á¦ÇÑ °­È­·Î ÀÎÇÑ Àü ¼¼°è °æÁ¦ ¹× ¹«¿ª¿¡ ´ëÇÑ ºÎÁ¤Àû ¿µÇâÀ¸·Î ±× È¿°ú°¡ ´õ¿í ±¤¹üÀ§ÇÏ°Ô ³ªÅ¸³¯ °ÍÀÔ´Ï´Ù.

³ë³â Àα¸ Áõ°¡´Â ÇâÈÄ À§ ¿°Àü Ä¡·á ½ÃÀå È®ÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ³ëÀÎ Àα¸´Â ¸é¿ª·Â ÀúÇÏ¿Í ³ëÈ­·Î ´Ù¾çÇÑ Áúȯ¿¡ Ãë¾àÇÑ 65¼¼ ÀÌ»ó °í·ÉÀÚ¸¦ ÀǹÌÇÕ´Ï´Ù. À§ ¿°ÀüÀº ÁÖ·Î 50¼¼ À̻󿡼­ ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼­ ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù ¹Ì±¹ ºñ¿µ¸® ±â°üÀÎ Àα¸ÂüÁ¶±¹(PRB)ÀÇ Åë°è¿¡ µû¸£¸é, 65¼¼ ÀÌ»ó ¹Ì±¹ÀÎ Àα¸´Â 2022³â 5,800¸¸ ¸í¿¡¼­ 2050³â±îÁö 8,200¸¸ ¸íÀ¸·Î 47% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ Àüü Àα¸¿¡¼­ Â÷ÁöÇÏ´Â ºñÁßÀº 17%¿¡¼­ 23%·Î Áõ°¡ÇÒ Àü¸ÁÀÔ´Ï´Ù. µû¶ó¼­ Áõ°¡ÇÏ´Â ³ëÀÎ Àα¸´Â À§ ¿°Àü Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Gastric volvulus treatment involves surgical interventions, specifically focusing on volvulus reduction and the reintegration of the stomach into the abdominal cavity, especially in cases of intrathoracic migration. The treatment also addresses the correction of causal factors. Gastric volvulus surgery is typically a straightforward procedure, encompassing de-rotation, lowering of hernial contents into the abdominal wall, and repair of the hernial defect.

The main types of gastric volvulus treatment are organo-axial and mesentero-axial volvulus. Organo-axial volvulus occurs when the abdomen undergoes a 180-degree spin around its long axis, resulting in this condition. Treatment options include medication and surgery, with various routes of administration such as oral and parenteral. Distribution channels for these treatments include hospital pharmacies and retail pharmacies, serving purposes in hospitals, home healthcare, specialty clinics, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The gastric volvulus treatment market research report is one of a series of new reports from. The Business Research Company that provides gastric volvulus treatment market statistics, including gastric volvulus treatment industry global market size, regional shares, competitors with a gastric volvulus treatment market share, detailed gastric volvulus treatment market segments, market trends and opportunities, and any further data you may need to thrive in the gastric volvulus treatment industry. This gastric volvulus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric volvulus treatment market size has grown strongly in recent years. It will grow from $27.36 billion in 2024 to $28.86 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to advancements in surgical techniques, improved diagnostic technologies, awareness and education, rise in minimally invasive procedures, research and clinical studies.

The gastric volvulus treatment market size is expected to see strong growth in the next few years. It will grow to $37.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to regulatory changes and approvals, innovations in surgical procedures, growing geriatric population, customized treatment plans, adoption of advanced imaging techniques. Major trends in the forecast period include minimally invasive surgical techniques, awareness and early intervention, research in treatment modalities, collaborative medical practices, and customized treatment approaches.

The forecast of 6.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper emergency surgical care by increasing the cost of laparoscopic reduction instruments and nasogastric tubes sourced from Brazil and China, thereby delaying life-saving interventions and elevating general surgery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

A growing geriatric population is projected to drive the expansion of the gastric volvulus treatment market in the future. The geriatric population refers to older adults aged 65 and above, who are prone to various diseases due to decreased immunity and aging. Gastric volvulus is primarily seen in individuals over the age of 50. Consequently, the increase in the geriatric population is expected to boost the market. For example, in January 2024, statistics from the Population Reference Bureau (PRB), a US-based nonprofit organization, indicated that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is projected to grow from 17% to 23%. Therefore, the rising geriatric population is a key driver of the gastric volvulus treatment market.

The rising prevalence of gastrointestinal diseases is anticipated to drive the growth of the gastric volvulus treatment market in the upcoming years. Gastrointestinal diseases refer to medical conditions that affect the internal structures of the gastrointestinal (GI) tract, often referred to as gastrointestinal disorders, including ailments such as gastritis, inflammatory bowel disease, and gastric cancer. The comprehensive care provided during gastric volvulus treatment may encompass strategies and considerations that enhance the overall health of the gastrointestinal system and its related disorders. For example, in September 2022, Cancer Australia, an organization focused on cancer awareness and support for individuals affected by cancer in Australia and its territories, reported that there were an estimated 2,572 new cases of stomach cancer expected to be diagnosed in Australia in 2022 (1,661 males and 911 females). In 2022, the likelihood of developing stomach cancer by age 85 was 1 in 114 (or 0.87%), with the odds being 1 in 1.1 (87%) for men and 1 in 167 (0.60%) for women. Thus, the increasing incidence of gastrointestinal diseases is propelling the gastric volvulus treatment market.

Product innovations emerge as a prominent trend gaining traction in the gastric volvulus treatment market. Major companies in the market are introducing innovative products to maintain their competitive positions. For instance, in October 2023, Pfizer Inc., a pharmaceutical company based in the United States, announced the FDA approval of VELSIPITY (etrasimod) for people with moderate to severe active ulcerative colitis. This once-daily oral sphingosine-1-phosphate (S1P) receptor activator offers a positive benefit-risk profile, providing adults with an effective, steroid-free resolution through a convenient oral pill.

Companies operating in the gastric volvulus treatment market are focusing on product innovations such as digital radiology solutions to enhance radiologists' efficiency. A digital radiology solution involves leveraging digital technology in medical imaging for visualizing internal body structures and aiding in the diagnosis and management of conditions such as gastric volvulus through digital image capture and analysis. For instance, in February 2023, Carestream Health India Pvt. Ltd. launched the DRX Compass, a digital radiological solution designed for accuracy, convenience, and customization. This innovative solution empowers radiologists with heightened productivity and flexibility in configuring the system based on individual requirements.

Key players in the gastric volvulus treatment market are concentrating on developing innovative solutions like advanced hyperbaric oxygen therapy to improve access to cutting-edge medical treatments, thereby enhancing patient outcomes and community health. Advanced hyperbaric oxygen therapy (HBOT) is a medical procedure that involves inhaling 100% oxygen in a pressurized chamber, which enhances oxygen delivery to tissues and promotes healing. This therapy may prove beneficial in the treatment of gastric volvulus by improving tissue oxygenation and aiding recovery from ischemia or surgical procedures. For example, in December 2024, HBOT India, a medical facility in India that specializes in hyperbaric oxygen therapy, introduced Medical Grade 3 ATA Hyperbaric Oxygen Therapy. This treatment enhances healing by increasing oxygen absorption, making it effective for chronic wounds, decompression sickness, and various other conditions. Its launch in Gurgaon significantly broadens access to advanced medical treatments in the area, thereby supporting the health and well-being of the community.

Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gastric volvulus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric volvulus treatment market includes revenues earned by entities that perform laparotomy, gastric detorsion, and gastric fixation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Volvulus Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric volvulus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for gastric volvulus treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric volvulus treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Gastric Volvulus Treatment Market Characteristics

3. Gastric Volvulus Treatment Market Trends And Strategies

4. Gastric Volvulus Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gastric Volvulus Treatment Growth Analysis And Strategic Analysis Framework

6. Gastric Volvulus Treatment Market Segmentation

7. Gastric Volvulus Treatment Market Regional And Country Analysis

8. Asia-Pacific Gastric Volvulus Treatment Market

9. China Gastric Volvulus Treatment Market

10. India Gastric Volvulus Treatment Market

11. Japan Gastric Volvulus Treatment Market

12. Australia Gastric Volvulus Treatment Market

13. Indonesia Gastric Volvulus Treatment Market

14. South Korea Gastric Volvulus Treatment Market

15. Western Europe Gastric Volvulus Treatment Market

16. UK Gastric Volvulus Treatment Market

17. Germany Gastric Volvulus Treatment Market

18. France Gastric Volvulus Treatment Market

19. Italy Gastric Volvulus Treatment Market

20. Spain Gastric Volvulus Treatment Market

21. Eastern Europe Gastric Volvulus Treatment Market

22. Russia Gastric Volvulus Treatment Market

23. North America Gastric Volvulus Treatment Market

24. USA Gastric Volvulus Treatment Market

25. Canada Gastric Volvulus Treatment Market

26. South America Gastric Volvulus Treatment Market

27. Brazil Gastric Volvulus Treatment Market

28. Middle East Gastric Volvulus Treatment Market

29. Africa Gastric Volvulus Treatment Market

30. Gastric Volvulus Treatment Market Competitive Landscape And Company Profiles

31. Gastric Volvulus Treatment Market Other Major And Innovative Companies

32. Global Gastric Volvulus Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastric Volvulus Treatment Market

34. Recent Developments In The Gastric Volvulus Treatment Market

35. Gastric Volvulus Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â